163 related articles for article (PubMed ID: 108706)
1. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
Stewart RM; Campbell A; Sperk G; Baldessarini RJ
Psychopharmacology (Berl); 1979 Feb; 60(3):281-9. PubMed ID: 108706
[No Abstract] [Full Text] [Related]
2. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
Pranzatelli MR; Snodgrass SR
Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
[TBL] [Abstract][Full Text] [Related]
3. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
Mueller RA; Towle A; Breese GR
Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 5,7-dihydroxytryptamine-induced supersensitivity to 5-hydroxytryptophan in mice by treatment with cycloheximide.
Sperk G; Stewart RM; Campbell A; Baldessarini RJ
Brain Res; 1978 Dec; 159(1):183-94. PubMed ID: 310331
[TBL] [Abstract][Full Text] [Related]
5. Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine.
Warbritton JD; Stewart RM; Baldessarini RJ
Brain Res; 1980 Feb; 183(2):355-66. PubMed ID: 6153283
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
[No Abstract] [Full Text] [Related]
8. Similar motor effects of 5-HT and TRH in rats following chronic spinal transection and 5.7-dihydroxytryptamine injection.
Barbeau H; Bédard P
Neuropharmacology; 1981 May; 20(5):477-81. PubMed ID: 6165921
[No Abstract] [Full Text] [Related]
9. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR
Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814
[TBL] [Abstract][Full Text] [Related]
10. Denervation supersensitivity to 5-hydroxytryptophan in rats following spinal transection and 5,7-dihydroxytryptamine injection.
Barbeau H; Bédard P
Neuropharmacology; 1981 Jun; 20(6):611-6. PubMed ID: 6972494
[No Abstract] [Full Text] [Related]
11. Changes in motor behavior following the administration of serotonin neurotoxins.
Growdon JH
Ann N Y Acad Sci; 1978 Jun; 305():510-23. PubMed ID: 309302
[No Abstract] [Full Text] [Related]
12. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
Pranzatelli MR; Rubin G; Snodgrass SR
Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
[TBL] [Abstract][Full Text] [Related]
13. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
Pranzatelli MR; Dollison AM; Hlibczuk V
Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
[TBL] [Abstract][Full Text] [Related]
14. 1-5-Hydroxytryptophan-induced flat body posture in the rat: antagonism by ritanserin and potentiation after 5,7-dihydroxytryptamine.
Colpaert FC; Koek W; Lategan A
Eur J Pharmacol; 1989 Oct; 169(1):175-8. PubMed ID: 2513211
[TBL] [Abstract][Full Text] [Related]
15. Supersensitivity to L-5-hydroxytryptophan after 5,7-dihydroxytryptamine injections in desmethylimipramine- and nomifensine-pretreated rats: behavioral evidence for postsynaptic supersensitivity.
Ortmann R; Martin S; Waldmeier PC
Psychopharmacology (Berl); 1981; 74(2):109-14. PubMed ID: 6115443
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the neurocytotoxicity of 5,7-dihydroxytryptamine by pharmacologic agents in adult and developing rats.
Breese GR; Mueller RA
Ann N Y Acad Sci; 1978 Jun; 305():160-74. PubMed ID: 280248
[No Abstract] [Full Text] [Related]
17. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
Black RS; Robinson RG
Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
[TBL] [Abstract][Full Text] [Related]
18. The guinea pig myoclonic model: behavioral supersensitivity to 5-hydroxytryptophan induced by intracisternal 5,7-dihydroxytryptamine.
Pranzatelli MR; Snodgrass SR
Eur J Pharmacol; 1987 Nov; 143(2):237-42. PubMed ID: 3500866
[TBL] [Abstract][Full Text] [Related]
19. Increased tilt-cage activity after serotonin depletion by 5,7-dihydroxytryptamine.
Mackenzie RG; Hoebel BG; Norelli HC; Trulson ME
Neuropharmacology; 1978 Nov; 17(11):957-63. PubMed ID: 152872
[No Abstract] [Full Text] [Related]
20. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.
Saller CF; Stricker EM
Neuropharmacology; 1978 Jul; 17(7):499-506. PubMed ID: 692815
[No Abstract] [Full Text] [Related]
[Next] [New Search]
